Barr warfarin lobbying support costs company $1.5 mil. in fourth quarter.
Executive Summary
BARR SPENT $1.5 MIL. IN WARFARIN-RELATED LOBBYING IN 4TH QUARTER, contributing to a drop in net earnings from $1.7 mil. for the three months ending June 30, 1996 to $527,000 for the equivalent period in 1997, the firm said. Barr's lobbying expenses accounted for more than half of the $2.5 mil. spent on warfarin in the fourth quarter.